 |
|
 |
 |

Home > Company Index > Health Products & Services > Medical Laboratories & Research > Interleukin Genetics, Inc.
 |
Interleukin Genetics, Inc. |
 |
 |
 |
PROFILE |
 |
Interleukin Genetics develops genetic tests to identify individuals' chances of developing certain diseases. Its first commercial product, the PST, is a test for gum disease and is available in the US, Israel, and Europe. The company is also developing predictive tests for such conditions as restenosis (the closure of arteries after angioplasty), osteoporosis, coronary artery disease, and diabetes-related blindness. An alliance with Sheffield University in the UK gives Interleukin Genetics access to biotechnology research in molecular genetics. Its BioFusion technology, created with GlaxoSmithKline, develops computer models of complex disease that drug researchers can use to test their drug candidates.
COMPETITION |
 |
Axys Pharmaceuticals, Inc. (AXPH)
Genome Therapeutics Corp. (GENE)
Myriad Genetics, Inc. (MYGN)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 0.30
1-Yr. Sales Growth: (40.0)%
Employees: 13
Revenue per employee: $23,076.92
KEY PEOPLE |
 |
Philip R. Reilly
CEO
Fenel M. Eloi
CFO
CONTACT INFO |
 |
135 Beaver St., 2nd Fl.
Waltham, MA 02452
US
Phone: 781-398-0700
Fax: 781-398-0720
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |